Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
105.70
+0.09 (0.09%)
At close: Jul 31, 2026, 4:00 PM EDT
106.04
+0.34 (0.32%)
After-hours: Jul 31, 2026, 7:52 PM EDT
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Devices | 22.52B | 22.03B | 21.39B | 20.76B | 20.06B | 19.43B | 18.99B | 18.38B | |||||||||||||||||||
| Medical Devices Growth | 12.22% | 13.40% | 12.65% | 12.99% | 12.22% | 11.40% | 12.43% | 13.48% | |||||||||||||||||||
| Diagnostics | 9.98B | 9.06B | 8.94B | 9.00B | 9.16B | 9.18B | 9.34B | 9.36B | |||||||||||||||||||
| Diagnostics Growth | 8.99% | -1.29% | -4.33% | -3.79% | -2.48% | -3.50% | -6.48% | -13.05% | |||||||||||||||||||
| Nutrition | 8.25B | 8.32B | 8.45B | 8.64B | 8.55B | 8.49B | 8.41B | 8.32B | |||||||||||||||||||
| Nutrition Growth | -3.50% | -1.99% | 0.45% | 3.82% | 2.69% | 2.86% | 3.18% | 4.90% | |||||||||||||||||||
| Established Pharmaceuticals | 5.82B | 5.70B | 5.54B | 5.42B | 5.32B | 5.23B | 5.19B | 5.15B | |||||||||||||||||||
| Established Pharmaceuticals Growth | 9.42% | 9.07% | 6.58% | 5.32% | 4.05% | 2.45% | 2.53% | 1.74% | |||||||||||||||||||
| Other | 16.00M | 16.00M | 17.00M | 17.00M | 17.00M | 16.00M | 16.00M | 15.00M | |||||||||||||||||||
| Other Growth | -5.88% | - | 6.25% | 13.33% | 13.33% | 14.29% | 14.29% | 15.38% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International | 28.41B | 27.90B | 27.20B | 26.76B | 26.12B | 25.70B | 25.63B | 25.29B | |||||||||||||||||||
| International Growth | 8.77% | 8.57% | 6.15% | 5.83% | 3.75% | 2.98% | 3.93% | 4.33% | |||||||||||||||||||
| United States | 18.17B | 17.23B | 17.13B | 17.08B | 16.99B | 16.65B | 16.32B | 15.93B | |||||||||||||||||||
| United States Growth | 6.98% | 3.53% | 4.92% | 7.24% | 9.27% | 8.30% | 5.64% | 1.33% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative | 13.95B | 13.01B | 12.33B | 12.11B | 11.95B | 11.80B | 11.70B | 11.51B | |||||||||||||||||||
| Selling, General, and Administrative Growth | 16.66% | 10.27% | 5.43% | 5.18% | 5.40% | 5.86% | 6.83% | 2.82% | |||||||||||||||||||
| Research and Development | 3.16B | 2.99B | 2.94B | 2.96B | 2.90B | 2.88B | 2.84B | 2.80B | |||||||||||||||||||
| Research and Development Growth | 8.85% | 4.07% | 3.45% | 5.76% | 5.41% | 3.79% | 3.76% | 1.05% | |||||||||||||||||||
| Amortization | 1.92B | 1.68B | 1.68B | 1.73B | 1.78B | 1.83B | 1.88B | 1.89B | |||||||||||||||||||
| Amortization Growth | 8.28% | -7.78% | -10.44% | -8.92% | -7.55% | -6.21% | -4.48% | -4.39% |